Similar articles

• [Breakthrough pain--what to consider when treating with rapid onset opioids].

  Loeser B, Zöllner C. Loeser B, et al. MMW Fortschr Med. 2011 Jun 9;153(23):86-9; quiz 90. MMW Fortschr Med. 2011. PMID: 21688502 Review. German. No abstract available.
• Pharmacokinetic and pharmacodynamic issues in the treatment of breakthrough pain.

  Cleary JF. Cleary JF. Semin Oncol. 1997 Oct;24(5 Suppl 16):S16-13-9. Semin Oncol. 1997. PMID: 9381223 Review. No abstract available.
• [Recommended use of morphine in children for postoperative pain relief. Pain and Locoregional Anesthesia Committee and the Standards Committee of the French Society of Anesthesia and Intensive Care].

  Gall O; Comité douleur-anesthésie locorégionale et le comité des référentiels de la Sfar. Gall O, et al. Ann Fr Anesth Reanim. 2009 Feb;28(2):e43-7. doi: 10.1016/j.annfar.2008.12.002. Epub 2009 Jan 16. Ann Fr Anesth Reanim. 2009. PMID: 19150592 French. No abstract available.
• [Are there indications for oral or sublingual administration of morphines?].

  Spielvogel C. Spielvogel C. Cah Anesthesiol. 1994;42(2):219-21. Cah Anesthesiol. 1994. PMID: 8087638 French.
• Rectal, buccal, and sublingual narcotics for the management of cancer pain.

  Ripamonti C, Bruera E. Ripamonti C, et al. J Palliat Care. 1991 Spring;7(1):30-5. J Palliat Care. 1991. PMID: 2045992 Review.